News | July 08, 2009

SNM Funds Molecular Imaging, Nuclear Medicine Research with $175K Grant

July 8, 2009 - As part of its ongoing support of nuclear medicine and molecular imaging research, SNM—an international scientific and professional organization of more than 17,000 members dedicated to promoting the practical applications, technology and science of molecular imaging and nuclear medicine—awarded $175,000 in research grants through its Education and Research Foundation at the society's 56th Annual Meeting, held June 13–17 in Toronto. 
"These awards fuel the future of molecular imaging and nuclear medicine research and encourage young clinicians and scientists to excel in their chosen field," said Alexander J.B. McEwan, M.D., past chair of SNM's Awards Committee. "We appreciate the ongoing support of individual donors, which paves the way for the next generation of researchers to further improve medical diagnosis and therapy."

"Advancing molecular imaging and therapy is an essential step in achieving more accurate and timely diagnoses," said Robert W. Atcher, Ph.D., M.B.A., current chair of SNM's Awards Committee. "SNM is proud to support research that will provide physicians with better tools to understand disease and monitor treatments."

The Molecular Imaging Research Grant for Junior Medical Faculty awards $100,000 over two years to support one junior faculty member in an academic research setting to engage them in molecular imaging research for diagnostic or therapeutic applications. The grant was presented to Laura L. Horky, M.D., Ph.D., of Brigham and Women's Hospital in Boston, Mass., to support research using FLT-PET and FET-PET for the early assessment of glioblastoma multiforme—the most common and aggressive type of brain tumor.

The Postdoctoral Molecular Imaging Scholar Program award provides $60,000 over two years in support of a postdoctoral fellow to promote integration of molecular imaging into their research activity. This year's award went to Changquing Li, Ph.D., of the University of California, Davis, to support research of the simultaneous use of PET and optical imaging, which could hold promise for patients with many devastating diseases.

The SNM/Covidien Seed Grant in Nuclear Medicine Research—which awards $25,000 to a researcher conducting a new and innovative pilot project that shows potential for future support from foundations, corporations or government agencies—was given to Rama Pichika, Ph.D., of the University of California, San Diego, for molecular imaging of early Alzheimer's disease.

Two pilot research grants of $25,000 each were presented to assist basic or clinical scientists in the early stages of their careers in conducting research that may lead to further funding. Ruth Lim, M.D., of Massachusetts General Hospital in Boston was awarded the Mitzi and William Blahd, M.D., Pilot Research Grant, to compare molecular imaging methods of low-grade cartilage tumors. Wawrzyniec Lawrence Dobrucki, Ph.D., of Yale University in New Haven, Conn., received the SNM Pilot Research Grant for the use of noninvasive SPECT-CT to detect diabetes after myocardial infarction (heart attack).

Delphine Chen, M.D., of the Mallinckrodt Institute of Radiology at the Washington University School of Medicine in St. Louis, Mo., received the Mark Tetalman Award—a $5,000 award honoring the efforts and accomplishments of a researcher age 36 years or younger who is no more than seven years from obtaining a Ph.D. or certification in nuclear medicine or nuclear radiology.

The SNM Student Fellowship Awards support students' clinical and basic research in molecular imaging and nuclear medicine by offering $3,000 to fund full-time research for up to three months. The Bradley-Alavi Student Fellowship Award, given to the top-ranked candidate, was awarded to Amanda Weinmann of the University of Minnesota Medical School in Minneapolis for research in molecular breast imaging. Other Student Fellowship Award recipients included:

• Chiun-Wei Huang of the University of Southern California Molecular Imaging Center in Los Angeles for prostate cancer research;

• Landon Locke of the University of Virginia in Charlottesville, Va., for multimodality imaging of leukocytes—white blood cells that fight infectious disease; and

• Lauren Sasportas of the Stanford University School of Medicine in Stanford, Calif., for work in revascularization—or increasing blood flow—after tumor irradiation.

For more Information:

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Overlay Init